The briefing
A Swedish study reports that patients with Alzheimer’s disease and atrial fibrillation on newer oral anticoagulants (NOACs) experienced slower cognitive decline. Researchers note the findings are observational and warrant further investigation before guiding care.
Original headline
Newer blood thinners linked to slower Alzheimer’s decline